The emerging therapy of the medication represents a major development in the handling of type 2 diabetes. Unlike existing medications, tirzepatide targets two pathways – the GLP-1 hormone and GIP – providing https://tirzepatidepeptide358686.bloggadores.com/40773686/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment